performed and were unremarkable. She had a mild anaemia and persistently raised CRP. Her initial autoimmune screen showed no abnormality. An outpatient CT chest, abdomen and pelvis showed a small pericardial effusion and noevidence of malignancy. In July 2014 she was reviewed in the rheumatology clinic and in view of her symptom profile and persistently raised inflammatory markers in the absence of infection, this raised the possibility of a systemic inflammatory problem related to a vasculitis. The recent CT imaging was reviewed at the rheumatology/radiology MDT and the radiologists felt that there was some probable inflammatory change in the aorta and some wall thickening. Further investigations with PET CT confirmed inflammatory changes in the large vessels and IgG subclasses were elevated at 2.06g/L. She was started on treatment for LVV and possible IgG4 disease, initially with 40mg prednisolone and MMF was later introduced. A repeat PET in May 2015 was normal. In January 2016 she developed sudden ataxia, hyporeflexia and weakness. She was found to have positive anti-gq1 antibodies and diagnosed with Miller-Fisher syndrome. Her symptoms resolved with an increase in the prednisolone dose. She had 3 further hospital admissions, each with similar symptoms of collapse and loss of consciousness, which was subsequently felt to be due to AI. Discussion: In this patient presenting with fevers and raised inflammatory markers, the initial investigations were rightly aimed at trying to identify a source of infection as this is the main concern in a patient with an ongoing pyrexia. Reviewing the images in clinic and at our MDT meeting identified the thickened aortic wall. This was key in providing further information as to what might be the cause of the patient's presentation and led us to order the appropriate and more detailed investigations in the form of PET CT and IgG subclasses. It was not possible in this case to get a histological diagnosis and therefore, based on the elevated IgG subclasses and PET findings, a presumptive diagnosis of IgG4 related disease and LVV was made. The initial treatment choice of prednisolone 40mg is based on current practice for treating LVV. In view of the IgG4 disease and after discussion with the Immunologists, it was decided that MMF would be the most appropriate steroid-sparing agent. This case highlights the fact that making adiagnosis of largevesselvasculitis is somewhatdifficult due to the non-specific clinicalpresentationsand laboratory findings. Once the diagnosis was made, this raised the question as to whether the pulmonary hypertension was in any way connected to the LVV or coincidental. This case also highlights the fact that patients with several immune-related diseases can develop further autoimmune conditions. In this case she was initially diagnosed with a LVV and IgG4-related disease then Miller-Fisher syndrome and following that adrenal insufficiency. Is this phenomenonbecoming more common inclinicalpractice? One other point for discussion is the choice of steroid-sparing agent, in this case we opted for MMF. Is there a case forrituximab in this patient? Key learning points: This case illustrates the fact that looking at previous imaging was crucial at providing further information and decide on further imaging that would aid in the diagnosis. The CT images were reviewed with the relevant laboratory findings, clinical picture and asking the right questions to the radiologists. In this case, we asked them to have a look at the large vessels in more detail as this can sometimes be missed and not properly looked at if the radiologists are not asked to specifically look at the large vessels. The differential diagnosis for these patients are broad and include infection, malignancy and inflammatory conditions such as a vasculitis or autoinflammatory disorder. Therefore keeping an open mind where these patients are concerned is important, especially in exploring the rarer causes of sucha presentation. There is no single diagnosis to explain all the symptoms experienced by the patient. The presence of one autoimmune disease should alert one to watch for another onein these patients. A multi-disciplinary team approach to the management of these complex patients with several autoimmune disorders, is essential. Reviewing the images with the radiologists helped identify thickening of the aortic wall. The regional immunology team was also involved in discussions about long-term management. The Neurology team was also involved and diagnosed Miller-Fisher syndrome. Conflicts of interest: The authors have declared no conflicts of interest.
BINOCULAR SIGHT LOSS: UNCOMMON, YET A DEVASTATING COMPLICATION OF GCA
Liubov Borukhson 1 , Abdul Kayani 1 , and Bhaskar Dasgupta 1 1 Rheumatology, Southend University Hospital, Southend, United Kingdom Introduction: GCA (giant cell arteritis) affects cranial branches of the arteries from aortic arch, especially the superficial temporal artery and vessels supplying the eye. Ophthalmic manifestations of GCA are characterised by the vasculitis of the ophthalmic artery and its branches. We present a case of a patient who developed the binocular sequential permanent vision loss secondary to GCA due to the delayeddiagnosis. Case description: A seventy-six year-old lady with a background of type two diabetes mellitus, hypertension and dyslipidemia and hemicolectomy for appendix tumour two years ago (no recurrence) was admitted with blurring of vision in the eye. She did not complain about other symptoms, however, on direct questioning she admitted six weeks history of weight loss (2.5 stones), severe tiredness and occasional night sweats, mild left sided temporal headache. She was initiated on 60mg of prednisolone. One week prior to admission she had right eye CRAO diagnosed by the ophthalmology team with preceding three weeks history of right eye blurring of vision. CRP at that time was 12 g/L and GCA was not considered likely. Following her permanent right sided vision loss, she was referred to stroke team for further management and was given aspirin. Her CT and MRI brain scans were unremarkable, USS carotid arteries revealing diffuse intimal thickeningin all the arteries of the neck. On assessment in the rheumatology fast track clinic she denied any associated jaw/tongue/arms claudication and no proceeding or historical PMR symptoms. She had mild left sided temporal artery tenderness and decreased temporal artery pulses bilaterally, no vision in the right eye along with the blurring in the left eye. There were no audible bruits in carotid, axillary, femoral arteries. Her acute phase maker (CRP) was mild but persistently elevated with a maximum level of 12 g/L for one week prior the admission. USS showed features consistent with GCA with extensive non-compressible halo signs in temporal arteries and its branches bilaterally. An urgent ophthalmology review revealed AION changes in the left eye, her vision deteriorated over the next forty-eight hours despite the initiation of high dose intravenous methylprednisolone. The patient was also started on tocilizumabinfusion inan attempt to reverse the sight loss. Discussion: The ophthalmic manifestations of GCA range from AION (anterior ischaemic optic neuropathy), CRAO (anterior central retinal artery occlusion), cilioretinal artery occlusion to occipital lobe infarcts, transient monocular vision loss, photopsias or diplopia. Ophthalmic GCA is an emergency and requires urgent ophthalmological evaluations and initiation of treatment with high dose of steroids to avoid permanent loss of vision. The reported incidence of visual symptoms in GCA ranges widely from 12% to 70% of cases. GCA is often associated with constitutional symptoms such as weight loss, night sweats, fevers, systemic inflammatory response with elevated inflammatory markers. However, it had been reportedthat this can be very mild inischaemic GCA. The diagnosis of GCA in this particular case was delayed for approximately six weeks due to the atypical initial presentation with mainly constitutional symptoms and unilateral vision blurring as well as mildly elevated inflammatory markers. A collaboration of three teams (namely ophthalmology, stroke and rheumatology) proved necessary to initiate high dose steroid treatment and tocilizumab. However, patient still suffered from permanent binocular vision loss. She was registered blind and will infuturerequire extensive physical and psychological support. Key learning points: Despite the recent advances and increased awareness with good availability of fast track GCA services, cases of bilateral blindness are still observed. This is due to a lack of awareness of atypical non-cranial symptoms that frequently accompany a GCA ischaemic presentation. Inflammatory markers are often only mildly elevated in such cases. We suggest a heightened public and professional awareness program to mitigate this irreversible disastrous complication. Conflicts of interest: The authors have declared no conflicts of interest. Introduction: This case discusses a 60-year-old old gentleman who had aggressive disease and severe complications of giant cell arteritis. Shortly after diagnosis of GCA, he had an aortic dissection which was successfully repaired surgically. Medical therapy was escalated by increasing steroids and initiating tocilizumab, which was continued for one year as per NICE guidance. Within 4 weeks of ceasing tocilizumab, GCA flared symptomatically and serologically. He was promptly restarted on tocilizumab, to which he responded. 2 months later he collapsed, and resuscitation attempts were unsuccessful. Post mortem examination revealed ruptured aortic aneurysm. Case description: A 60-year-old old retired gentleman presented with left sided headache and blurred vision. CRP and ESR were 80 and 100 respectively. Temporal artery biopsy confirmed giant cell arteritis. He commenced 60mg prednisolone with good response and weaned according to BSR guidance. Past medical history included Barrett's POSTER PRESENTATIONS 27 September 2019 i45
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